Cargando…
E-vape and E-Cigarettes-Associated Lung Injury (EVALI) in the COVID-19 Pandemic: A Diagnostic Dilemma and Therapeutic Challenge
E-vape and e-cigarettes-associated lung injury (EVALI) is a diagnostic dilemma and even more obscure during the coronavirus disease 2019 (COVID-19) pandemic. A rise was seen in EVALI cases at the beginning of the COVID-19 pandemic. Still, the non-specific presentation, or the overlapping symptoms of...
Autores principales: | Mandal, Gaurav, Lale, Ajit, Greco, Rick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216167/ https://www.ncbi.nlm.nih.gov/pubmed/35754440 http://dx.doi.org/10.7759/cureus.26200 |
Ejemplares similares
-
E-cigarette or Vaping Product Use-Associated Lung Injury Complicated by Pulmonary Aspergillosis
por: Kupelian, Chloe, et al.
Publicado: (2021) -
E-CIGARETTE OR VAPING USE-ASSOCIATED LUNG INJURY (EVALI): EFFECTS OF VAPING OR COVID-19?
por: WALBRIDGE, GEORGE, et al.
Publicado: (2022) -
Suggested management of e-cigarette or vaping product use associated lung injury (EVALI)
por: Hage, René, et al.
Publicado: (2020) -
E-cigarette or Vaping Product Associated Lung Injury (EVALI) Presenting As Cardiac Arrest
por: Schekochikhina, Natalia, et al.
Publicado: (2022) -
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)
por: Muthumalage, Thivanka, et al.
Publicado: (2020)